FTT PET/CT in Metastatic Prostate Cancer
Condition(s):Prostate Cancer MetastaticLast Updated:April 18, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer MetastaticLast Updated:April 18, 2023Recruiting
Condition(s):Cancer; Metastatic CancerLast Updated:March 15, 2024Not yet recruiting
Condition(s):Liver Neoplasms; Hepatic Cirrhosis; Hepatic Carcinoma; Liver Cancer; Liver Metastases; Liver Carcinoma; Hepatocellular Carcinoma; Hepatocellular Cancer; Hepatic AtrophyLast Updated:January 31, 2024Active, not recruiting
Condition(s):Metastatic or Recurrent Gynecological TumorsLast Updated:February 14, 2022Recruiting
Condition(s):Wild-type RAS Metastatic Colorectal CancerLast Updated:November 8, 2022Completed
Condition(s):Breast Cancer With Brain MetastasisLast Updated:March 18, 2020Withdrawn
Condition(s):Metastatic Breast CancerLast Updated:January 31, 2019Withdrawn
Condition(s):Metastatic Breast CancerLast Updated:March 8, 2017Completed
Condition(s):Colorectal Cancer MetastaticLast Updated:September 25, 2023Not yet recruiting
Condition(s):Metastatic Breast Cancer With HER2 Positive; Triple Negative Breast CancerLast Updated:October 27, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.